医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Cigna and Samsung Team Up to Deliver Digital Health Improvement Platform Worldwide

2013年10月28日 PM11:25
このエントリーをはてなブックマークに追加


 

BLOOMFIELD, Conn. & SEOUL, South Korea

Global health service company Cigna and the world’s largest manufacturer of mobile devices, Samsung Electronics Co. Ltd., have signed a multi-year agreement to co-develop health and wellness related features built into Samsung’s S Health on Samsung’s major smart mobile devices.

The initial development is focused on delivering health-related tips and articles through the Samsung S Health Application, with an ultimate goal of connecting individuals with caregivers, doctors and hospitals to improve health and wellness globally.

“With this agreement, we are pioneering a new health service model of innovation by establishing a strategic alliance between global leaders in the mobile industry and the health industry,” said Won-Pyo Hong, President of Media Solution Center from Samsung.

“Cigna is committed to helping people improve their health, well-being and sense of security with fun and engaging mobile tools to make better health part of their everyday life,” said Benjamin Karsch, Cigna’s Head of Brand, Marketing Communications and Digital Marketing. “Samsung’s innovative products are a fun and engaging part of the lives of people in nearly 80 countries. By teaming up with the global leader in smart mobile devices, we are putting the power to embrace better health literally into the hands of millions of people around the world.”

S Health is a Samsung initiative to collect and integrate health information for consumers from smartphones and personal health devices and provide easy to use features in a mobile dashboard to help make health improvement an engaging part of everyday life. Cigna will provide the content, experience and engines for valuable clinical insights.

Cigna content is incorporated into Samsung Galaxy Note 3 in select countries, including United States, United Kingdom, France, Germany, Italy, and Spain beginning in October 2013. Over the next year, additional co-developed functions and features will find their way to Samsung’s mobile devices worldwide.

About Cigna

Cigna Corporation (NYSE:CI) is a global health service company dedicated to helping people improve their health, well-being and sense of security. All products and services are provided exclusively through operating subsidiaries of Cigna Corporation, including Connecticut General Life Insurance Company, Cigna Health and Life Insurance Company, Life Insurance Company of North America, Cigna Life Insurance Company of New York and their affiliates. Such products and services include an integrated suite of health services, such as medical, dental, behavioral health, pharmacy and vision care benefits, and other related products including group disability, life, and accident coverage. Cigna has sales capability in 30 countries and jurisdictions, with approximately 80 million customer relationships throughout the world. To learn more about Cigna®, including links to follow us on Facebook or Twitter, visit www.cigna.com.

About Samsung Electronics

Samsung Electronics Co., Ltd. is a global leader in technology, opening new possibilities for people everywhere. Through relentless innovation and discovery, we are transforming the worlds of televisions, smartphones, personal computers, printers, cameras, home appliances, LTE systems, medical devices, semiconductors and LED solutions. We employ 270,000 people across 79 countries with annual sales exceeding US$187.8 billion. To discover more, please visit www.samsung.com.

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20131028005937/en/

CONTACT

Cigna
Joe Mondy, +1 860-226-5499
Joseph.mondy@cigna.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • BioVectra与Keryx Biopharmaceuticals签署枸橼酸铁扩产协议
  • Eternity Healthcare Inc. Enters into Share Exchange Agreement with Guizho Tongren Healthy China Biotechnology Co. Ltd.
  • Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease
  • Chi-Med Initiates Fruquintinib U.S. Clinical Trials
  • Orthocell Granted European Tendon Regeneration Patent